Agata Mazurkiewicz-Gorgol

DG COMP (Brussels)
Case officer

Agata is Case officer at European Commission.

Linked authors

DG COMP (Brussels)
DG COMP (Brussels)

Articles

1500 Bulletin

Agata Mazurkiewicz-Gorgol, Arthur Stril The EU Commission clears acquisition of pharmaceutical company, with effects in the market for biosimilars, subject to remedies that ensure innovation competition (Pfizer / Hospira)

276

Pfizer / Hospira: Through the lookingglass: assessing competition by biosimilars* In a nutshell In Pfizer/Hospira, the Commission assessed biosimilar drugs in detail for the first time. Biosimilars aim to have the same therapeutic mechanism as, and be clinically equivalent to, original (...)

Send a message